APA Citatie

Sin Leo, Y., Wilder-Smith, A., Archuleta, S., Shek, L. P., Chong, C. Y., Nam Leong, H., . . . Crevat, D. (2012). Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years: Phase II randomized controlled trial in Singapore. Landes Bioscience.

Chicago Style citaat

Sin Leo, Yee, et al. Immunogenicity and Safety of Recombinant Tetravalent Dengue Vaccine (CYD-TDV) in Individuals Aged 2–45 Years: Phase II Randomized Controlled Trial in Singapore. Landes Bioscience, 2012.

MLA citatie

Sin Leo, Yee, et al. Immunogenicity and Safety of Recombinant Tetravalent Dengue Vaccine (CYD-TDV) in Individuals Aged 2–45 Years: Phase II Randomized Controlled Trial in Singapore. Landes Bioscience, 2012.